鼻アレルギ-に対するN-5′錠の臨床評価

概要

論文の詳細を見る
N-5′ tablets were given to 36 patients with nasal allergy for 4 consecutive weeks.Subjective improvement was noted in 77.7% and over-all improvement in 80.6%. The effects of this drug appeared within 1 week in 46.4%, within 2 weeks in 71.4% and within 3 weeks in all patients.In 81.3% of the patients sneezing attacks were reduced, in 76.5% nasal discharge and in 72.2% nasal obstruction. Patients with sneezing and nasal discharge had better relief of symptoms than did those with nasal obstruction.Abdominal pain and nausea were noted in one case, but these were not severe and disappeared after medication was stopped.Synthetic evaluation showed moderate improvement in 77.8% and great improvement in 27.8%. Therefore, the authors consider that N-5′ tablets can be recommended for the treatment of nasal allergy.